Viemed Healthcare (VMD) 2nd Annual Lytham Partners Healthcare Investor Summit summary

Business overview and differentiation

• Specializes in home-based complex respiratory therapy, serving patients with severe COPD and neuromuscular diseases.

• Diversified product mix includes sleep apnea, oxygen therapy, behavioral health, staffing, and maternal health.

• High-touch model integrates respiratory therapists into hospital care teams and leverages proprietary technology for patient monitoring.

• Sales process focuses on training clinicians as sales reps, creating a unique competitive advantage.

Strategic evolution and growth

• Transitioned from a 90% ventilator-focused business to a diversified portfolio through organic growth and targeted M&A.

• Published clinical data demonstrating reduced mortality and hospital admissions, establishing industry leadership.

• Recent CMS national coverage determination (NCD) provides a regulatory edge and supports further expansion.

• Completed three acquisitions to fill geographic and product gaps, notably Lehan's Medical for sleep and maternal health.

Financial performance and revenue streams

• Achieved a 27% revenue CAGR, driven by expansion into underserved markets and growth in sleep apnea services.

• Approximately 70% of revenue is recurring, primarily from equipment rentals; 30% is transactional.

• Maintains positive net income and free cash flow, with low net debt and periodic share buybacks.

• EBITDA margins are stable in the low 20% range, with potential for future expansion through operating leverage.